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Blood systems biology seeks to quantify outside-in signaling as platelets respond to
numerous external stimuli, typically under flow conditions. Platelets can activate via GPVI
collagen receptor and numerous G-protein coupled receptors (GPCRs) responsive to ADP,
thromboxane, thrombin, and prostacyclin. A bottom-up ODE approach allowed prediction
of platelet calcium and phosphoinositides following P2Y1 activation with ADP, either for a
population average or single cell stochastic behavior. The homeostasis assumption (i.e., a
resting platelet stays resting until activated) was particularly useful in finding global steady
states for these large metabolic networks. Alternatively, a top-down approach involving
Pairwise Agonist Scanning (PAS) allowed large data sets of measured calciummobilization
to predict an individual’s platelet responses. The data was used to train neural network
(NN) models of signaling to predict patient-specific responses to combinatorial stimulation.
A kinetic description of platelet signaling then allows prediction of inside-out activation of
platelets as they experience the complex biochemical milieu at the site of thrombosis.
Multiscale lattice kinetic Monte Carlo (LKMC) utilizes these detailed descriptions of
platelet signaling under flow conditions where released soluble species are solved by
finite element method and the flow field around the growing thrombus is updated
using computational fluid dynamics or lattice Boltzmann method. Since hemodynamic
effects are included in a multiscale approach, thrombosis can then be predicted under
arterial and venous thrombotic conditions for various anatomical geometries. Such
systems biology approaches accommodate the effect of anti-platelet pharmacological
intervention where COX1 pathways or ADP signaling are modulated in a patient-specific
manner.
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INTRODUCTION
A systems biology approach for platelets seeks to predict
kinetic processes during clotting or bleeding episodes. A mul-
tiscale modeling framework should facilitate the bridging of
genomics/proteomics studies with platelet phenotype and vessel
pathophysiology under hemodynamic conditions. Such a frame-
work should quantify risks and severity of such episodes for a
given phenotype/genotype as well as the safety and efficacy of
pharmacological intervention.
PLATELET GENOMICS
Genome-wide association studies (GWAS) have found rather
modest associations of SNPs (single nucleotide polymorphisms)
with thrombosis or vascular disease (Wellcome Trust Case
Control Consortium, 2007; Ouwehand, 2007). A GWAS focused
specifically on coronary artery disease (CAD) identified 4 loci
linked to CAD (Samani et al., 2007), but mechanistic understand-
ing of these SNPs awaits exploration and may not necessarily be
platelet-linked. Jones et al. (2007) measured platelet response,
calcium mobilization, aggregometry, and FACS determination of
response to ADP or GPVI activation with collagen-related peptide
(CRP) in 506 healthy volunteers to define inter-individual vari-
ability. Importantly, SNPs in the GP6 locus were linked to about
35% of the variation in response to CRP. Variability in response
to ADP was associated with polymorphisms in the platelet P2Y12
receptor (Fontana et al., 2003). However, it currently remains dif-
ficult to use GWAS or genotyping information to predict risk
for a specific patient. Greliche et al. (2013) conclude from their
genome-wide SNP interaction analysis that common SNPs were
unlikely to have strong interactive impact on the risk of venous
thrombosis. Few if any genomic studies quantitatively predict an
individual’s blood function during clotting or bleeding disease
scenarios under hemodynamic conditions.
PLATELET TRANSCRIPTOME AND PROTEOMICS
Platelets contain a microRNA (miR) pool and a translatable
mRNA pool that declines with a platelet’s age in the circula-
tion. McRedmond et al. (2004) identified 2928 mRNA species
using Affymetrix arrays. Many of the top 50 most abundant
platelet mRNAs correlated with secreted or membrane proteins
such as β2-microglobulin, platelet factor 4, factor XIII, GPIb,
αIIb, etc. Similarly, Gnatenko et al. (2003) found 2147 mRNA
species and Bugert et al. (2003) found 1526 mRNA species in
purified platelets. More recent direct sequencing methods iden-
tified ∼9000 mRNA species in platelets (Bray et al., 2010),
more comparable in size to the transcriptome of megakaryocytes.
Also, platelets contain a functional spliceosome. For example,
the processing of tissue factor (TF) mRNA and translation of
TF upon platelet activation was found in activated platelets
(Schwertz et al., 2006), although TF activity was only detectable
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in sonicated platelet membranes. The human platelet proteome
has been examined and an important web-based resource is now
available to explore protein-protein interactions within platelets
(Boyanova et al., 2011).
Inter-individual variation in platelet reactivity, even in a nor-
mal population, has been associated with a number of factors
including: female gender, fibrinogen level, ethnicity, inherited
variations, and polymorphisms (Hetherington et al., 2005; Bray,
2007). Unfortunately, no single genomic or proteomic factor
is a strong predictor of hyper-reactivity in typical subjects and
the need for advanced functional phenotyping motivates the
development of systems biology tools to quantify blood function.
CLOTTING UNDER FLOW CONDITIONS
Collagen is sufficient to capture and activate platelets under
venous wall shear rates (γw ∼100–200 s−1). In the arte-
rial circulation (γw ∼1000–2000 s−1), collagen adsorbed von
Willebrand factor (vWF) facilitates platelet capture, allowing col-
lagen induced GPVI signaling and subsequent α2β1 and α2bβ3
activation. Under flow conditions, red blood cells help enrich the
platelet concentration by∼3–8× in the plasma layer near the wall.
At pathological high shear exposures (>5000 s−1) encountered in
severe stenosis, mechanical heart valves, and continuous LVAD
pumps, the plasma vWF may undergo structural changes such as
a transition from a globular to an extended state (Schneider et al.,
2007), likely increasing the availability of A1 domains in the vWF
polymer for multivalent contacting with platelet GPIb receptors.
Interestingly, severe stenosis and LVAD pumps can lead to an
acquired von Willebrand disease, demonstrating the importance
of local hemodynamics on the systemic circulation.
GROWTH OF THE PLATELET AGGREGATE VIA AUTOCATALYTIC
SIGNALING
Collagen triggers GPVI clustering, leading to rapid phosphory-
lation of the GPVI-associated Fc receptor by Src family tyrosine
kinases. Such phosphotyrosine residues are recognized by Syk,
and the binding and activation of Syk activates PLCγ2. PLCγ2
converts phosphatidylinositol (PI)-4,5-P2 (PIP2) to inositol 1,4,5-
trisphosphate (1,4,5-IP3 or IP3) and diacyclglycerol (DAG). IP3
opens Ca2+ channels in the platelet dense tubular system (DTS).
Depletion of DTS Ca2+ results in STIM1 activation and bind-
ing to Orai1, leading to store operated calcium entry (SOCE).
DAG/Ca2+ activates protein kinase C (PKC) in platelets, which
in turn governs several serine/threonine phosphorylation events.
Beyond the first monolayer of platelets adherent to colla-
gen/VWF, the addition of subsequent layers of platelets to the
growing thrombus is strongly potentiated by locally released ADP
and thromboxane (TXA2) as well as locally generated thrombin.
FIGURE 1 | Detailed reaction schemes for platelet signaling modules.
Four interconnected models were defined: (A) Ca2+ module: cytosolic
and DTS compartments are separated by the DTS membrane, which
contains the IP3R and SERCA. (B) Phosphoinositide (PI) module:
Membrane-bound PIs are cleaved by PLC-β to form diffusible inositol
phosphates and DAG, which are substrates for resynthesis of PIs. (C)
PKC module: Ca2+i and DAG activate PKC, which migrates to the
plasmamembrane where it phosphorylates PLC-β. (D) P2Y1 module:
extracellular ADP binds to and activates P2Y1. Active P2Y1 accelerates
guanine nucleotide exchange on bound Gq. The Gq·GTP binds and
activates PLC-β, which increases the GTPase activity of Gq·GTP.
Molecular kinetic descriptions are embedded in the signaling modules
for: (E) SERCA catalytic cycle (Dode et al., 2002): Subscripts: E1, facing
cytosol; E2, facing DTS; P, phosphorylated. (F) IP3R dynamics (Sneyd
and Dufour, 2002): Subscripts: n, native; i1, inhibited; o, open; a, active;
s, shut, i2, inhibited. (G) PKC activation: Active kinase is bound to
Ca2+i and DAG and located at the PM. Subscripts: M, located at the
PM; C, Ca2+-bound; D, DAG-bound. (H) P2Y1 activation module: Rate
equations describing the interactions among ADP, P2Y1, and Gq were
modeled according to the ternary complex model described in
Kinzer-Ursem and Linderman (2007). Abbreviations: A, ADP; P, P2Y1; G,
Gq. ∗Ca2+ both activates and inhibits IP3R.
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ADP activates P2Y1 and P2Y12 while TXA2 activates the TP
receptor and thrombin cleaves PAR1 and PAR4. Activation of a
GPCR causes an exchange of GTP for GDP on the α subunit of
the G protein and dissociation of the α and βγ subunits. Both
these units in turn interact with secondary effectors such as PLCβ
and adenylate cyclase. Human platelets express at least 10 forms
of Gα (including members of the Gq, Gi, G12, and Gs fami-
lies) (Brass et al., 2006; Offermanns, 2006). Thrombin, ADP, and
TXA2 activate PLCβ via Gq. PLCβ generates IP3 from membrane
PIP2. Rising Ca2+ levels activate the Ras family member, Rap1B
via Cal-DAG GEF. Rap1B activation is a precursor to αIIbβ3 acti-
vation and allows the platelets to form aggregates with other
platelets through fibrinogen cross-bridging. Ca2+-dependent sig-
naling drives myosin light chain kinase and activation of GTP
binding proteins of the Rho family (Klages et al., 1999). Rho acti-
vation in turn activates kinases like p160ROCK and 5 LIM-kinase
that can phosphorylate myosin light chain kinase and cofilin
to regulate actin-dependent cytoskeletal shape changes (Pandey
et al., 2006).
Endothelial derived prostacyclin (PGI2) binds the IP recep-
tor and causes Gs mediated increase in adenyl cyclase activity.
Also, NO from the endothelium and platelets can activate guany-
late cyclase resulting in elevated cGMP levels that subsequently
inhibit the hydrolysis of cAMP by intracellular phosphodi-
esterases. Taken together these mechanisms elevate intracellular
cAMP levels, which strongly downregulate platelet signaling.
Agonists coupled to Gi family members inhibit cAMP production
in platelets, thus allowing activation to proceed unhindered (Yang
FIGURE 2 | Homeostasis requirement: Assembly of full model from
steady-state modules using principle component analysis (PCA). The
full model is assembled by combining PCA-reduced, steady-state solution
spaces from each module into a combined steady state solution space.
This global space is searched for full-length, steady-state solution vectors
that satisfy both the steady state requirements of each module and the
desired time-dependent properties when the steady-state is perturbed. A
simple linear constraint is imposed for every pair of modules that share
a common molecule ci to ensure that steady state solutions are
consistent. To assemble the platelet signaling model, a set of 16 PC
vectors representing all 72 unknown variables in the model were used as
search directions in a global optimization routine. The global solution
space was searched for models with accurate dynamic behavior using
experimental time-series data for ADP-stimulated Ca2+ release. Species
are grouped according to compartment. Color values correspond to molar
concentrations (mol/L or mol/m2) or as indicated: ∗DTS species (mol
L−1). †Extracellular species (mol L−1). ‡DTS volume (L). §PM leak
conductance/area (S m−2).
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et al., 2002). Additionally the βγ subunits of these receptors can
activate PLCβ and the γ isoform of PI3K. The effectors for PI3K
include Rap1b and Akt (Woulfe et al., 2002).
ADP is stored in platelet dense granules and is released upon
activation. P2Y1 and P2Y12 are the primary receptors for this
agonist. P2Y1 is Gq coupled and signaling through this receptor
causes Ca2+ mobilization, shape change, and thromboxane gen-
eration. P2Y12 is the target of the commonly used anti-platelet
drug Plavix, and is a Gi2 coupled receptor that inhibits cAMP
production in platelets.
Thrombin is a potent platelet agonist that causes fast mobi-
lization of intracellular Ca2+, and activation of phospholipase
A2 and subsequent thromboxane generation (Offermanns et al.,
1997). Also, thrombin can trigger Rho dependent signaling
pathways in platelets (Moers et al., 2003), that contribute to
actin modeling and shape change. Thrombin signals through
the protease-activated receptor (PAR) family of GPCRs. PAR1
and PAR4 are expressed on human platelets, while PAR3 and
PAR4 are expressed on mouse platelets. Thrombin cleaves the
N-terminus of these receptors, exposing a new N-terminus that
serves as a tethered ligand for these receptors. Synthetic pep-
tides are able to selectively activate these receptors and mimic
the actions of thrombin (for example, SFLLRN for PAR1, and
AYPGKF for PAR4). Kinetic studies have shown that the human
platelet response to thrombin is biphasic and involves first signal-
ing through PAR1 and subsequent signaling through PAR4 (Covic
et al., 2000). In mouse platelets signaling occurs primarily via
PAR4, and is facilitated by PAR3. In addition to the PAR recep-
tors, GP1bα has high affinity for thrombin. Absence of GP1bα
reduces responses to low doses of thrombin and diminishes
PAR1 signaling, suggesting that this receptor facilitates signaling
through the PARs (Dormann et al., 2000). Ca2+ mobilization also
activates phospholipase A2 (PLA2), which in turn converts mem-
brane phospholipids to arachidonic Acid. TXA2 is produced from
membrane arachidonate by the aspirin sensitive cyclooxygenase
(COX-1) enzyme. TXA2 causes Ca2+ mobilization, aggregation,
secretion, phosphoinositide hydrolysis, and protein phosphoryla-
tion. TXA2 can diffuse across the membrane and activate nearby
platelets, but its activity is limited by the molecule’s short half life
(∼30 s).
SYSTEMS BIOLOGY MODELS OF PLATELET-VESSEL WALL
INTERACTIONS
BOTTOM-UP MODEL OF ADP ACTIVATION OF P2Y1 RECEPTOR
In our representation of P2Y1 activation (Figure 1) (Purvis et al.,
2008), binding of extracellular ADP to P2Y1 leads to activation of
Gq through GDP/GTP exchange reactions. Gq·GTP is a substrate
for GTPase activating proteins (GAPs) such as PLC-β and RGS4,
which can accelerate Gq·GTPhydrolysis over 1000-fold. Although
other ADP receptors are involved in platelet Ca2+ signaling
(e.g., P2X1 and P2Y12), the P2Y1 receptor (∼150 copies/platelet)
contributes 90% of the Ca2+ signal.
Because of the inherent complexity in a model of this size,
we constructed four signaling “modules”: (1) Ca2+ release
and uptake (Figure 1A), (2) phosphoinositide (PI) metabolism
(Figure 1B), (3) PKC regulation of phospholipase C-β (PLC-
β) (Figure 1C), and (4) P2Y1 G-protein signaling (Figure 1D).
These modules use previously validated or data-consistent kinetic
networks for SERCA, IP3-Receptor, PKC translocation, and
GPCR signaling (Figures 1E–H).
Assembling the four modules together results in a global ODE
model that has 77 reactions, 132 fixed kinetic rate constants, and
70 species. Since the reaction network (Figure 1) and the kinetic
parameters are fixed, the reaction topology of the model is also
fixed. Such a model takes the general form: dc/dt = F(c) and c(t
= 0) = co where c is a vector of all species concentrations and co
is a specified initial condition vector at t = 0.
To determine appropriate sets of co that are suitable for use in
modeling platelets, a challenge exists that the copy number of each
species in a resting platelet is not known. Imposing a homeostasis
assumption results in powerful tool to define a set of acceptable co
vectors. The homeostasis assumption states that a resting platelet
remains resting until activated. This means that an acceptable ini-
tial condition co also represents a steady state for the system and
will satisfy the equation dc/dt = 0. Finding a global co involves
assembling the steady state solutions of each module (Figure 2).
The first phase of the method involves generating a com-
pact representation of the steady-state solutions for each module.
First, conservative bounds are chosen for c based on physiological
and practical considerations. Also, because molecular concentra-
tions can span several orders of magnitude, it is most efficient
to delineate this range of values on a logarithmic scale rather
FIGURE 3 | Tests of P2Y1 signaling model. ADP dose response for
the full platelet model from 100 nM to 10μM ADP for calcium
mobilization (A) or IP3 generation (B). Stochastic simulation of a
single platelet (C). A single, fura-2-loaded platelet was immobilized on
a fibrinogen-coated coverslip and activated with 40μM ADP at t = 90
[Ca2+ trace from Heemskerk et al. (2001)]. After 90 s of simulated
rest, the platelet model was activated by setting extracellular [ADP] to
40μM. Simulated interval times were binned in 2 s increments for
direct comparison with experiment (inset).
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than a linear scale. Once the sampling distribution for c has been
defined, steady-state solutions (co = css) for each module are cal-
culated using fixed kinetic parameters for each reaction in the
module. For non-oscillating systems, steady-state solutions may
be obtained by simulating the system until equilibrium is reached
(i.e., until dc/dt = 0). In the third step, a large collection of
steady-state solutions for each module is subjected to principal
component analysis (PCA) (Purvis et al., 2009). PCA is then used
to transform these points to a new coordinate set that optimally
covers the space of steady-state solutions using the fewest num-
ber of dimensions. For example, if two molecule concentrations
in the steady-state space are highly correlated due to participation
in the same reaction, PCA will locate a single dimension to rep-
resent each pair of points in the transformed space. Ultimately,
these new dimensions will be combined across all modules to
search for global solutions that lie in the steady-state space for the
fully combined network. Since PCA is a linear method, a steady-
state solution space that is highly nonlinear may require more
principal component vectors to accurately estimate the solutions.
The reduction procedure is shown for the human platelet model
comprising 4 interlinked signaling modules (Figure 2). For this
step, we generated more than 109 sets of initial guesses (co) for
each module, computed the initial value problem for each co
until a steady state was reached (dc/dt ≈ 0), and selected only
FIGURE 4 | Shifts in steady-state profiles caused by kinetic
perturbations. The steady-state platelet model was perturbed by changing
selected kinetic parameters (±10-fold) and simulating for 1 h. After
approaching a new steady state, the model concentrations and fluxes were
determined relative to their original steady-state values and colored according
to fold-change. Green indicates no change (NC) relative to initial
flux/concentration. Red indicates a relative increase and blue indicates a
relative decrease. Note that the color scale in each panel is normalized
separately to maximize distinctions in fold change. New steady states were
achieved after (top) 10-fold decrease in PKC-mediated inhibition of PLC-β, and
(bottom) 10-fold increase in PIP2 hydrolysis (10-fold increase in kcat of
hydrolysis). ∗, active state.
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those steady states (css) that were consistent with known con-
centrations (i.e., [Ca2+]o ∼100 nM). Interestingly, only a small
fraction of initial guesses produce steady-state solutions that are
also consistent with known concentration values. For example,
it was shown that only 50,000 of 109 initial guesses (0.005%) in
the Ca2+ balancemodule (Figure 1A) met both requirements and
were suitable for further analysis. This observation shows that the
kinetic topology of these molecular networks places very strong
constraints on the range of concentrations that can exist at steady
state. In biological terms, this suggests that fixed kinetic proper-
ties at the molecular level (e.g., IP3R and SERCA kinetics) can
affect not only the dynamical features of a biochemical system
but can also determine the abundance of chemical species and
the compartmental structures that contain them. A fully assem-
bled initial condition vector results (bottom, Figure 2) results in
new hypotheses about allowable concentrations and ratios of con-
centrations (i.e., IP3/SERCA ratio is very small). The allowed co
= css is consistent with the known resting levels of Ca2+, IP3,
P2Y1, DAG, PA, PI, PIP2, and PIP (bottom, Figure 2) as well as
the stimulated response of platelets to increasing amounts of ADP
(right, Figure 2). With a global simulation of P2Y1 signaling, it is
possible to simulate the ADP dose-response of calciummobiliza-
tion and IP3 generation in platelets as well as the mobilization
of intracellular calcium in a single platelet due to stochastic
fluctuations (Figure 3).
Since many initial condition vectors can be found to allow a
resting platelet to remain resting and then respond appropriately
to stimulation, investigation of these multiple steady states and
associated cell responses can allow an ad-hoc sensitivity analysis.
Some species (flexible nodes) may vary widely in the allowed ini-
tial condition vectors but have little effect on system response. In
contrast, other species (rigid nodes) may be forced to take on val-
ues in a very narrow range due to the kinetic constraints of the
problem.
To examine the changes in steady-state properties caused by
kinetic perturbations in the P2Y1 model, we altered the rates of
important regulatory reactions and observed the system response
to each perturbation. Each perturbation cause a brief adjustment
phase lasting ∼200 s followed by a more gradual phase char-
acterized by a new steady-state profile. After 1 h of simulated
time, steady-state concentrations and reaction fluxes were quan-
tified relative to their original steady-state levels (Figure 4). In a
computational perturbation, the inhibition of phospholipase C-
β (PLC-β) activity by PKC was reduced 10-fold. Since PKC has
a negative-feedback role in suppressing the platelet-stimulating
activity of PLC-β, this perturbation caused a 2-fold increase
FIGURE 5 | Pairwise agonist scanning to predict global calcium
response in human platelets. (A) Simplified schematic of signaling
pathways examined in this study that converge on intracellular calcium
release in human platelets. (B) Dynamic NN model used to train
platelet response to combinatorial agonist activation. A sequence of
input signals representing agonist concentrations is introduced to the
network at each time point. Processing layers integrate input values
with feedback signals to predict the next time point. (C) A total of
154 calcium traces were measured for single and pairwise activation
using 6 different agonists (“Experiment”) and used for neural network
training. The NN training accurately predicted (“NN Prediction”) the
training data.
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FIGURE 6 | Multiscale modeling. The multiscale model has four main
components (A) fluid flow, transport of soluble species, motion and binding
of platelets, and the activation state of each platelet. The fluid flow is
perturbed by the growing clot and is determined using the lattice
Boltzmann method. The released soluble agonists form a boundary layer in
the flow, and this process is determined using the finite element method.
Platelet motion and bonding are simulated with lattice kinetic Monte Carlo.
Platelet activation state is estimated from the history of intracellular
calcium concentration, which is determined by a neural network model.
(B) Multiscale simulation of patient-specific platelet deposition under flow
for a specific donor and PAS-trained neural network of calcium signaling.
Platelet activation (black, unactivated; white, activated) and deposition at
500 s (inlet wall shear rate, 200 s−1) showing released ADP (top) and TXA2
(middle) and perturbation of the flow field (bottom). Flow: left to right
(streamlines, black lines); surface collagen (250μm long): red bar.
in steady-state PIP2 hydrolysis, elevated IP3 concentration, and
accelerated Ca2+ release. This was a compensatory effect caused
by the negative feedback loop involving Ca2+-regulated activity
of PKC, a resulting new hypothesis that can be probed experi-
mentally. In another example, increasing the hydrolytic activity
of PLC-β for the substrate PIP2 by 10-fold caused an expected
stimulatory effect, raising intracellular calcium and steady-state
levels of cytosolic inositol phosphates (IP3, IP2, and IP) between
2- and 3-fold. Interestingly, reaction fluxes for phosphoinositide
hydrolysis were diminished, possibly due to substrate depletion.
Taken together, these examples illustrate the system-wide effects
of perturbations in the kinetic rate processes. The procedure
could easily be extended to examine multiple simultaneous per-
turbations in both reaction rates and steady-state concentrations.
In future applications of this approach, genomic or proteomic
information of multiple perturbations could be used to help
predict platelet signaling phenotypes.
TOP-DOWN SIGNALING APPROACHES
The prior example required about 200 parameters to describe
P2Y1 signaling. In contrast, top-down approaches in systems biol-
ogy allow the construction of large data sets to predict system
response without precise knowledge of intracellular pathways.
During thrombosis, platelets respond simultaneously to collagen
activation of GPVI and α2β1, ADP activation of P2Y1, P2Y12, and
P2X1, thromboxane activation of TP, and thrombin activation
of PAR1 and PAR4, while NO and PGI2 dampen responsiveness
(Figure 5A). We have developed a 384-well plate assay to measure
platelet calcium mobilization in response to single and pairwise
agonist stimulation at 0.1, 1, and 10XEC50, a method termed
PAS (Chatterjee et al., 2010). We developed a six agonist probe
set for activation of P2Y1/P2Y12, PAR1, PAR4, TP, IP, and GPVI
pathways and measured the EC50 for each agonist (ADP, EC50 =
1.17μM; SFLLRN, 15.2μM; AYPGKF, 112μM; U46619, 1.2μM;
PGE2, 25μM; and convulxin, 0.005μM). To capture how the 6
molecular signals are processed by activated platelet, we trained
a 2-layer neural network (NN) model (Figure 5B) that predicted
time-course behavior of the training set of pairwise combinations
of the six agonists (Figure 5C). We used a nonlinear autoregres-
sive network with exogenous inputs (NARX) model to predict
successive time points from all 154 Ca2+ release curves gathered
by experiment. The NN model, which was trained on pairwise
agonist stimulation with both agonists added simultaneously, was
successful in predicting response to sequential addition of ago-
nists and ternary agonist stimulation (Chatterjee et al., 2010).
With 4077 NN simulations fully spanning the 6 dimensional ago-
nist space, 45 combinations of 4, 5, and 6 agonists (predicted to
range from strong synergism to strong antagonism) were selected
and confirmed experimentally (R = 0.88), revealing a highly syn-
ergistic condition of high U46619/PGE2 ratio, consistent with the
known thrombotic risk of COX-2 therapy.
Furthermore, PAS provided 135 pairwise synergy values that
allowed a unique phenotypic scoring and differentiation of indi-
viduals. We measured synergy vectors for 10 healthy donors in
replicate. From clustering analysis, 7 of 10 donors self-clustered
when tested twice in a 2-week period, revealing at least two major
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phenotype classes. Thus, PAS offers a sensitive, patient-specific
experimental and computational platform for understanding how
a cell integrates many inputs. The trained NN is ideal for use in a
multiscale model of clotting under flow conditions.
PLATELET INTERACTIONS WITH THE VESSEL WALL
The multiscale systems biology model accommodates platelet sig-
naling, platelet adhesion to collagen and other activated platelets,
release of soluble agonists, thrombus growth, and distortion
of the prevailing flow field (Figure 6A). The lattice Boltzmann
(LB) method is used to solve for the velocity field of the fluid.
Platelets in the growing aggregate release ADP and TXA2 into
the fluid, and a boundary layer is formed with the flow. The
dynamics of this process are determined with a finite element
method solution of the convection-diffusion-reaction equation
for each of the soluble species, ADP and TXA2. Platelets move
in the fluid by convection and RBC-augmented dispersion. They
also bind to the collagen surface as well as previously bound
platelets. The motion and binding of platelets is simulated using
the convective lattice kinetic Monte Carlo (LKMC) algorithm
validated for stochastic convective-diffusive particle transport
(Flamm et al., 2009, 2011, 2012). The level of integrin activation
and associated adhesiveness for each platelet is related to the
cumulative intracellular calcium concentration. The intracellu-
lar calcium concentration is determined using a NN trained on
a specifc patient’s platelet PAS phenotyping experiment. Using
this multiscale approach, Multiscale simulations predicted the
density of platelets adherent to the surface, platelet activation
states, as well as the spatiotemporal dynamics of ADP and TXA2
release, morphology of the growing aggregate, and the distribu-
tion of shear along the solid-fluid boundary (Figure 6B). Platelets
stick to the collagen surface and release ADP and TXA2 which
forms a boundary layer extending up to 10μm from the throm-
bus. Boundary layer concentrations of up to 10μM ADP and
0.1μM TXA2 were found by simulation. TXA2 concentrations
were found to be sub-physiological (<0.0067μM or<0.1 xEC50)
until a sufficient platelet mass accumulated at the surface after
∼250 s. Boundary layer ADP concentrations were within the
effective dynamic range (0.1–10μM) throughout the simulation.
The strong temporal and spatial fluctuations in the concentration
of ADP were predominately driven by the short release time (5 s),
whereas the longer release time of TXA2 (100 s) smoothed fluc-
tuations. The shear rate along the solid-fluid boundary became
nonuniform during the simulation (5–10-fold increase above
200 s−1) due to surface roughness. At 500 s, the platelet deposit
was characterized by platelet clusters 20–30μm in length, fully
consistent with microfluidic measurements of platelet cluster
size on collagen at this shear rate (Colace et al., 2011). Platelet
accumulation rates on collagen as detected using microfluidic
chambers (Maloney et al., 2010) and were highly consistent with
simulation predictions for 3 separate donors (each with a trained
NN model) in the presence of TXA2 antagonism (indomethacin
or aspirin), ADP antagonism with a P2Y1 inhibitor, or IP activa-
tion (with iloprost).
CONCLUSION
For multi-scale modeling of platelet-vessel wall interactions, a
given modeling route at each scale has advantages and disad-
vantages. Top-down models (like NNs) are most easily obtained
in a patient-specific manner to describe platelet function, how-
ever they typically fail to identify specific intracellular regulators.
Bottom-up models (like ODE models) of platelet signaling pro-
vide molecular precision but face three challenges: (1) difficulty
in parameterization, (2) difficulty in fitting to high dimensional
data, and (3) incomplete knowledge. Both NN and ODE mod-
els are both relatively fast in terms of computational speed.
Lattice kinetic Monte Carlo (LKMC) methods provide a balance
of speed and sub-micron spatial precision, particularly for dis-
crete cellular systems over millimeter-scale phenomenon and 100
or 1000s of cells. LKMC methods are also relatively easy to pro-
gram and facilitate the passing of information with other lattice
based methods (like Lattice Boltzman or finite elements). LKMC
methods become exceedingly slow for molecular simulations of
large ensembles when time steps become impossibly small. For
solving 2D flow problems, Lattice Boltzman is relatively fast and
easy to implement and has no issues of numerical stability. One
of the biggest numerical challenges is solving multi-component,
reaction-diffusion problems with spatial gradients. Wall-derived
TF triggers coagulation and∼10–100 PDEsmust be solved to cal-
culate thrombin and fibrin levels in a growing thrombus. Solving
large PDE systems is especially computationally intensive (days or
weeks) and resists parallel processing.
A central goal in blood systems biology is to elucidate the
regulatory complexity of cellular signaling across a large ensem-
ble of interacting cells responding to numerous spatiotemporal
stimuli in the presence of pharmacological mediators, ideally in
a patient-specific and disease-relevant context (i.e., containing
hemodynamics). Developing tools to define platelet variations
between patients and the relationship of platelet phenotype to
prothrombotic or bleeding traits will have significant impact in
stratifying patients according to risk. This multiscale approach
also makes feasible patient-specific prediction of platelet deposi-
tion and drug response in more complex in vivo geometries such
as stenosis, aneurysms, stented vessels, valves, bifurcations, or ves-
sel rupture (for prediction of bleeding risks) or in geometries
encountered in mechanical biomedical devices.
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